Hyperion DeFi, Inc. (HYPD) vs XBiotech Inc. (XBIT)

Hyperion DeFi, Inc. and XBiotech Inc. are both Biotechnology companies. Hyperion DeFi, Inc. and XBiotech Inc. are of similar size ($65.9M and $64.8M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (−159.2% vs 2.73%). Across the 18 metrics below, XBiotech Inc. leads on 10 and Hyperion DeFi, Inc. on 8.

Valuation

Metric HYPD XBIT Biotechnology median
P/E n/m n/m 7.88
P/S 40.88 16.50 11.47
P/B 0.56 0.52 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 11.46 0.71 0.74
EV/Sales 40.02 (8.26) 10.73
Earnings yield (153.22%) (68.20%) (28.84%)
Free cash flow yield (134.77%) (61.95%) (23.03%)

Profitability

Metric HYPD XBIT Biotechnology median
Gross margin 78.35% 0.00% 65.16%
Operating margin 314.32% 0.00% 0.00%
Net margin (1,224.53%) 0.00% 0.00%
Free cash flow margin (5,509.35%) 0.00% 0.00%
Return on equity (24.63%) (29.94%) (57.72%)
Return on assets (20.32%) (28.90%) (49.22%)
Return on invested capital 2.73% (159.18%) 0.00%

Growth

Metric HYPD XBIT Biotechnology median
Revenue growth (TTM) 1,990.60% (78.20%) 5.64%
EPS growth (last fiscal year) 84.28% (18.25%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYPD XBIT Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 2.34 33.15 4.73
Net debt to EBITDA (0.03) 2.33 0.96

Dividend

Metric HYPD XBIT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HYPD XBIT Biotechnology median
Market cap 64.80m 65.85m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack